| Chairman |
|
An Youcai |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman & General Manager: An Youcai
Executive Director: Li Runxiang, He Yiming
Non-executive Director: Cheng Qianwen, Yu Jianlin, Du Mu
Independent Non-executive Director: Li Xiangming, Li Xiaoqing, Chen Chengbei.
|
| Principle Business |
|
The Group is principally engaged in the research and development, manufacturing and commercialization of vaccine products for human use in the PRC. |
| Major Shareholders |
| An Youcai | 113,830,052 | H Sh | 28.93% | 38.41% | 2025/08/11 | | An Youcai | 33,823,083 | NON-H SHS | 8.60% | 34.84% | 2025/08/11 | | Shi Fanhui & Family | 26,743,364 | H Sh | 6.80% | 9.02% | 2025/08/11 | | Jiangsu Jiequan Gaotejia Medical Industry Investment Fund | 14,854,442 | H Sh | 3.78% | 5.01% | 2025/08/11 | | Jiangsu Jiequan Gaotejia Medical Industry Investment Fund | 14,854,442 | NON-H SHS | 3.78% | 15.30% | 2025/08/11 | | Shanghai Wenzhou Investment Management Co., Ltd. | 11,912,802 | H Sh | 3.03% | 4.02% | 2025/08/11 | | Shanghai Wenzhou Investment Management Co., Ltd. | 9,757,945 | NON-H SHS | 2.48% | 10.05% | 2025/08/11 |
|
|
|
|
|